Bernstein Upgrade Meets a Stock Down 7% on the Week

DECK heads into its May 21 earnings with a fresh analyst upgrade arriving almost precisely as the stock suffers its worst weekly drop in months — and the market's reaction so far has been to lean bullish rather than defensive.

The most notable event this week is Bernstein's move on Wednesday. Analyst Aneesha Sherman upgraded Deckers from Underperform to Market Perform and lifted her price target from $90 to $100 — still barely above the current close of $98.54. That's a cautious upgrade: it acknowledges the stock's de-rating but stops well short of calling it a buy. It arrived against a backdrop of a 7.2% weekly decline in the share price, which puts Deckers roughly 6% below the year-end 2025 close and near the bottom of its recent range.

The Street's collective view remains mixed, though it leans toward patience rather than conviction. The consensus sits at a Hold, with 12 analysts there and one Underperform. The mean price target of $128.90 implies around 30% upside from current levels — but that aggregate is pulled higher by more bullish calls from UBS (target $161) and Barclays (Overweight, $143), while Goldman Sachs maintains a Sell with a $92 target that is now marginally below the stock price. The PE has compressed to around 13x, down roughly half a turn over the past month, and EV/EBITDA has drifted to just under 9x — both multiples sitting well below where they traded in 2025. The bull case centres on Hoka's international runway and margin resilience despite tariff headwinds; the bear case flags fashion-cycle risk for UGG and still-incomplete Hoka distribution in the US and Europe.

Options positioning tells a modestly constructive story. The put/call ratio has eased to 0.85, actually a touch below the 20-day average of 0.88, and the z-score of -0.92 shows options traders are less defensive than they've been over the past month. That's a mild positive shift — the PCR ran above 0.95 through most of April, when macro uncertainty was at its peak. Investors are not reaching aggressively for downside protection heading into the May 21 print.

Short interest gives little reason for alarm. At 2.6% of free float — with about 3.78 million shares short — the level is modest and has barely moved over the past five weeks. Borrowing costs are negligible at 0.5% annualised, and the lending pool is effectively wide open, with utilisation running near 1% against a 52-week peak of 11.6%. Nothing in the borrow market points to crowded short positioning. The ORTEX short score of 31.6 sits in the lower third of the universe, consistent with a name where shorts carry little conviction. The closest US-listed peer, ONON, shed 2.4% on the week — a softer performance but nowhere near the severity of DECK's slide — which suggests at least part of Deckers' drop reflects company-specific rather than sector-wide pressure.

What the May 21 results need to resolve is a question the data has already framed clearly. The last quarterly print in January delivered a 22% single-day surge and a 14% five-day follow-through — the biggest positive earnings reaction in recent memory. Before that, in October 2025, the stock fell 12% on the day and 21% over five days. The binary nature of those past moves, combined with a sell-down from several insiders at prices well above current levels in February — including the CFO and two divisional presidents — makes the upcoming print a genuine inflection point. With Bernstein's upgrade anchoring the floor near $90-100 and Goldman's Sell rating still live just below the current price, the range of outcomes into earnings looks as wide as it has been all year.